Eiken Chemical Co., Ltd.
2027 Fiscal Year First Quarter Financial Results Supplementary Explanation Materials
Eiken Chemical's financial results for the first quarter of fiscal year 2027 show net sales of approximately 10,728 million yen, a 5.2% increase YoY. Despite a 21.3% decrease YoY in operating profit to approximately 640 million yen, the company continues to contribute to medical fields through expanded sales of medical devices and test kits.
Key Figures
- Net Sales: 10,728 million yen (Up 5.2% YoY)
- Operating Profit: 640 million yen (Down 21.3% YoY)
- Net Income: 445 million yen (Down 25.8% YoY)
AI要約
Future Outlook and Impact on Investors
The company plans to continue strengthening sales of test kits and medical devices in response to the expanding demand in the healthcare sector. Through investments in research and development and the launch of new products, it aims for long-term growth. Investors should pay attention to contributions to medical fields, cost management, and the development of new markets.
Net Sales Trends
Operating Profit Trends
Net Income Trends
Eiken Chemical Co., Ltd.
Company overview · Stock price · Financial data · All IR
